Why the study?
Is cardiovascular autonomic function, measured by heart rate variability, impaired in patients with familial amyloidotic polyneuropathy compared to healthy volunteers?
Is cardiovascular autonomic function, measured by heart rate variability, impaired in patients with familial amyloidotic polyneuropathy compared to healthy volunteers?
Patients with familial amyloidotic polyneuropathy have impaired cardiovascular autonomic function as evidenced by reduced heart rate variability.
Impaired HRV in FAP suggests autonomic monitoring may be warranted; leaves open its prognostic utility pending prospective studies.
Familial amyloidotic polyneuropathy (FAP) is characterized by both sensimotor and autonomic dysfunction. Autonomic disturbance involving the gastrointestinal tract, the urinary bladder, the cardiac conduction system, and the peripheral circulation has been described. In this study simple, non-invasive tests of autonomic function based on heart rate variability were applied to 12 patients with FAP and 12 healthy volunteers. The heart rate variation during normal breathing, deep breathing and during tilt from recumbent to standing position was measured. All tests showed significantly less heart rate variation in patients than in controls and the heart rate variation decreased with increasing severity of neurological disability, but the small number of patients in our study does not allow any further comparison between subgroups. Our study thus indicates impaired cardiovascular autonomic function in patients with FAP and we believe that these findings might also be of importance in other forms of systemic amyloidosis.
No takes yet. Share an insight, caveat, or question.
Niklasson et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: